Nuclear medicine and molecular imaging

Nucl Med Mol Imaging · ISSN (print) 1869-3474 · 6 papers in corpus
article 2023
doi:10.1007/s13139-023-00796-4 ·PMID:37720883

A 47-year-old woman with history of hepatocellular carcinoma was referred for 18F-fluorocholine PET/CT evaluation due to elevated alpha-fetoprotein. The examination showed several peritoneal uptakes and two nodular pelvic foci. Coelioscopic…

2015
doi:10.1007/s13139-014-0303-3 ·PMID:25774237

PurposeOvarian cancer is a leading cause of gynecologic malignancy. As symptoms of ovarian cancer are nonspecific, only 20 % of ovarian cancers are diagnosed while they are still limited to the ovaries. Thus, early and accurate detection of…

2013
doi:10.1007/s13139-012-0186-0 ·PMID:24900097
2013
doi:10.1007/s13139-013-0197-5 ·PMID:24900087

PurposeBorderline ovarian tumors (BOTs) are more common in young women of reproductive age, and exhibit a better prognosis than malignant ovarian tumors (MOTs). Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/…

2013
doi:10.1007/s13139-012-0167-3 ·PMID:24895508

The whole body I-131 scan is routinely performed in the postoperative treatment of patients with well-differentiated thyroid cancer. Accurate interpretation of whole body I-131 scan after thyroidectomy is critical to appropriate management …

other 2010
doi:10.1007/s13139-010-0045-9 ·PMID:24899966

A 32-year-old female who suffered from abdominal pain underwent (18)F-fluorodexoyglucose (FDG) positron emission tomography/computed tomography (PET/CT) for the diagnostic workup of pelvic mass lesions. Cystic mass lesions in the bilateral …